Andrew M. Courtwright
( out of 13 reviews )

Andrew M. Courtwright, MD, PhD

Languages spoken: English

Clinical Locations

Primary Location

University of Utah Hospital

Pulmonary, Clinic 3
50 N Medical Dr
Salt Lake City , UT 84132
801-581-7806
Get Directions

University of Utah Hospital

Medical Intensive Care Unit
50 N Medical Dr
Salt Lake City , UT 84132
801-581-2121
Get Directions

Huntsman Cancer Institute - Cancer Hospital South

Medical Intensive Care Unit
1950 Circle of Hope
Salt Lake City , UT 84112
801-581-2121
Get Directions

Dr. Courtwright is a clinician in the Division of Pulmonary Medicine. He also maintains an adjunct appoint in the University of Utah Department of Philosophy. His clinical research focuses on telomere biology disorders in interstitial lung disease and lung transplantation. His philosophical work centers on issues in transplantation ethics, including organ allocation out of sequence, normothermic regional perfusion, and the role of incentives in living organ donation. He moved from Pennsylvania to Utah in 2025 to be closer to his extended family and to the mountain trails.

Specialties

Board Certification

American Board of Internal Medicine (Sub: Critical Care Medicine)
American Board of Internal Medicine (Internal Medicine)
American Board of Internal Medicine (Sub: Pulmonary Disease)

Patient Rating

5.0 /5
( out of 13 reviews )

The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers. The scale on which responses are measured is 1 to 5 with 5 being the best score.

2026-02-13
UNIVERSITY HOSPITAL

His expertise and diagnosis helped tremendously with curing my infected lungs. He is attentive, caring and respectful. Thank you Dr Andrew Courtwright from the bottom of my heart for relieving me from the distress I was going through for month

2026-01-29
UNIVERSITY HOSPITAL

Very helpful and kind

2026-01-28
UNIVERSITY HOSPITAL

Dr. Courtwright was very friendly and took time to address my concerns.

2025-12-17
UNIVERSITY HOSPITAL

Dr. Courtwright was very pleasant and kind. Very easy to talk to and a great listener. I felt like all of my concerns were addressed.

2025-12-13
UNIVERSITY HOSPITAL

Was great to talk with, very friendly. Felt he Listened to the me.

2025-11-19
UNIVERSITY HOSPITAL

Doctor Courtwright is an amazing pulmonologist with knowledge and experience that worked well with with all of my issues. Besides being a man with a great knowledge base, he listens and solves problems

2025-10-03
UNIVERSITY HOSPITAL

Dr. Courtwright is an amazing doctor! He took a lot of time to address all of my concerns and make sure I'm getting the best possible care. He has a lot of knowledge about my disease.

2025-09-20
UNIVERSITY HOSPITAL

Dr. Courtwright, was very congenital, and informative. He explained things in ways we could all understand. He made me feel confident in taking the next step for an evaluation.

2025-07-10
UNIVERSITY HOSPITAL

Thanks Dr Courtwright

Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

Dr. Courtwright is a clinician in the Division of Pulmonary Medicine. He also maintains an adjunct appoint in the University of Utah Department of Philosophy. His clinical research focuses on telomere biology disorders in interstitial lung disease and lung transplantation. His philosophical work centers on issues in transplantation ethics, including organ allocation out of sequence, normothermic regional perfusion, and the role of incentives in living organ donation. He moved from Pennsylvania to Utah in 2025 to be closer to his extended family and to the mountain trails.

Board Certification and Academic Information

Academic Departments Internal Medicine -Associate Professor (Clinical)
Academic Divisions Public Health
Board Certification
American Board of Internal Medicine (Sub: Critical Care Medicine)
American Board of Internal Medicine (Internal Medicine)
American Board of Internal Medicine (Sub: Pulmonary Disease)

Education history

Undergraduate Biology - Rice University B.A.
Undergraduate Philosophy - Rice University B.A.
Doctoral Training Philosophy, areas of specialization: normative ethics; biomedical ethics - University of North Carolina Chapel Hill Ph.D.
Professional Medical University of North Carolina Chapel Hill School of Medicine M.D.
Residency Internal Medicine - Massachusetts General Hospital Resident
Fellowship Pulmonary and Critical Care Medicine - Brigham and Women¿s Hospital Fellow
Fellowship Advanced Lung Disease and Lung Transplantation - Hospital of the University of Pennsylvania Fellow

Selected Publications

Journal Article

  1. Courtwright AM, Diamond JM, Sandorfi N, Goldberg HJ (2024). The Impact of Donor-Recipient Human Leukocyte Antigen Matching on Bronchiolitis Obliterans-Free Survival Among Lung Transplant Recipients With Connective Tissue Diseases. Clin Transplant, 38(8), e15426.
  2. Grobman B, Diamond JM, Goldberg HJ, Courtwright A (2024). The Impact of Prelung Transplant HLA Antibodies on Post-transplant Outcomes in Recipients With Autoimmune Lung Disease. Transplantation proceedings, 56(7), 1646-1653.
  3. Usman AA, Spelde AE, Lutfi W, Gutsche JT, Vernick WJ, Toubat O, Olia SE, Cantu E, Courtwright A, Crespo MM, Diamond J, Biscotti M, Bermudez C (2024). Percutaneous Venopulmonary Extracorporeal Membrane Oxygenation as Bridge to Lung Transplantation. ASAIO journal (American Society for Artificial Internal Organs, 70(9), 758-766.
  4. Marshall M, Diamond J, Goldberg H, Courtwright (2024). The impact of high volumes of COVID-related lung transplant on waitlist mortality for non-COVID candidates in the United States. Clinical transplantation, 38(2), e15250.
  5. Courtwright AM, Doyon JB, Blumberg EA, Cevasco M, Cantu E, Bermudez CA, Crespo M (2023). Infectious complications associated with bronchial anastomotic dehiscence in lung transplant recipients. Clinical transplantation, 37(10), e15040.
  6. Bermudez C, Bermudez F, Courtwright A, Richards T, Diamond J, Cevasco M, Blumberg E, Christie J, Usman A, Crespo M (2024). Lung transplantation for COVID-2019 respiratory failure in the United States: Outcomes 1-year posttransplant and the impact of preoperative extracorporeal membrane oxygenation support. The Journal of thoracic and cardiovascular surgery, 167(1), 384-395.e3.
  7. Courtwright AM, Patel N, Chandraker A, J Goldberg (2022). Human leukocyte antigen antibody sensitization, lung transplantation, and health equity. American journal of transplantation, 22(3), 698-704.
  8. Choi B, Messika J, Courtwright A, Mornex JF, Hirschi S, Roux A, Le Pavec J, Quêtant S, Froidure A, Lazor R, Reynaud-Gaubert M, Borgne AL, Houlbracq MP, Goldberg H, El-Chemaly S, Borie R, French Group of Lung Transplantatio (2022). Airway complications in lung transplant recipients with telomere-related interstitial lung disease. Clinical transplantation, 36(3), e14552.
  9. Courtwright AM, Kamoun M, Diamond JM, Kearns J, Ahya VN, Christie JD, Clausen E, Hadjiliadis D, Patel N, Salgado JC, Cevasco M, Cantu EE, Crespo MM, Bermudez C (2021). Lung transplantation outcomes after crossing low-level donor specific antibodies without planned augmented immunosuppression. Clinical transplantation, 35(11), e14447.
  10. Courtwright AM, Kamoun M, Kearns J, Diamond JM, Golberg H (2020). The impact of HLA-DR mismatch status on retransplant-free survival and bronchiolitis obliterans syndrome'free survival among sensitized lung transplant recipients. The Journal of heart and lung transplantation, 39(12), 1455-1462.
  11. Diamond JM, Courtwright AM, Balar P, Oyster M, Zaleski D, Adler J, Brown M, Hays SR, Sutter N, Garvey C, Kukreja J, Gao Y, Bruun A, Smith PJ, Singer J (2021). Mobile health technology to improve emergent frailty after lung transplantation. Clinical transplantation, 35(4), e14236.
  12. Drolen C, Cantu E, Goldberg HJ, Diamond JM, Courtwright (2020). Impact of the elimination of the donation service area on United States lung transplant practices and outcomes at high and low competition centers. American journal of transplantation, 20(12), 3631-3638.
  13. Courtwright AM, Lamattina AM, Takahashi M, Trindade AJ, Hunninghake GM, Rosas IO, Agarwal S, Raby BA, Goldberg HJ, El-Chemaly (2020). Shorter telomere length following lung transplantation is associated with clinically significant leukopenia and decreased chronic lung allograft dysfunction-free survival. ERJ open research, 6(2),
  14. Nathan AS, Blebea C, Chatterjee P, Thomasson A, Diamond JM, Groeneveld PW, Giri J, Goldberg HJ, Courtwright A (2020). Mortality trends around the one-year survival mark after heart, liver, and lung transplantation in the United States. Clinical transplantation, 34(6), e13852.
  15. Courtwright AM, Zaleski D, Tevald M, Adler J, Singer JP, Cantu EE, A Bermudez C, Diamond J (2019). Discharge frailty following lung transplantation. Clinical transplantation, 33(10), e13694.
  16. Aslam S, Courtwright AM, Koval C, Lehman SM, Morales S, Furr CL, Rosas F, Brownstein MJ, Fackler JR, Sisson BM, Biswas B, Henry M, Luu T, Bivens BN, Hamilton T, Duplessis C, Logan C, Law N, Yung G, Turowski J, Anesi J, Strathdee SA, Schooley R (2019). Early clinical experience of bacteriophage therapy in 3 lung transplant recipients. American journal of transplantation, 19(9), 2631-2639.
  17. Courtwright AM, Lamattina AM, Louis PH, Trindade AJ, Burkett P, Imani J, Shrestha S, Divo M, Keller S, Rosas IO, Goldberg HJ, El-Chemaly (2019). Hyaluronan and LYVE-1 and allograft function in lung transplantation recipients. Scientific reports, 9(1), 9003.
  18. Courtwright AM, Cao S, Wood I, Mallidi HR, Kawasawa J, Moniodis A, Ng J, El-Chemaly S, Goldberg H (2019). Clinical Outcomes of Lung Transplantation in the Presence of Donor-Specific Antibodies. Annals of the American Thoracic Society, 16(9), 1131-1137.
  19. Cho JK, Acord M, Goldfarb SB, Reddy SN, Goldberg HJ, Courtwright A (2019). Complications related to totally implantable venous access devices in children and adults following lung transplantation. Clinical transplantation, 33(2), e13465.
  20. Courtwright AM, Rubin E, Robinson EM, Thomasson A, El-Chemaly S, Diamond JM, Goldberg H (2019). In-hospital and subsequent mortality among lung transplant recipients with a prolonged initial hospitalization. American journal of transplantation, 19(2), 532-539.
  21. Courtwright AM, Rubin E, Robinson EM, El-Chemaly S, Lamas D, Diamond JM, Goldberg H (2019). An Ethical Framework for the Care of Patients with Prolonged Hospitalization Following Lung Transplantation. HEC forum, 31(1), 49-62.
  22. Cao S, Courtwright AM, Lamattina AM, Guleria I, Burkett P, El-Chemaly S, Goldberg H (2018). The impact of screening method on HLA antibody detection before and after lung transplantation: A prospective pilot study. The Journal of heart and lung transplantation, 37(4), 531-533.
  23. Courtwright AM, Zaleski D, Gardo L, Ahya VN, Christie JD, Crespo M, Hadjiliadis D, Lee J, Molina M, Patel N, Porteous M, Cantu EE, Bermudez C, Diamond J (2018). Causes, Preventability, and Cost of Unplanned Rehospitalizations Within 30 Days of Discharge After Lung Transplantation. Transplantation, 102(5), 838-844.
  24. Courtwright A, Diamond JM, Wood I, Guleria I, Milford E, El-Chemaly S, Goldberg H (2018). Detection and clinical impact of human leukocyte antigen antibodies in lung transplantation: A systematic review and meta-analysis. HLA, 91(2), 102-111.
  25. Courtwright AM, Burkett P, Divo M, Keller S, Rosas IO, Trindade A, Mody GN, Singh SK, El-Chemaly S, Camp PC, Goldberg HJ, Mallidi H (2018). Posttransplant Lymphoproliferative Disorders in Epstein-Barr Virus Donor Positive/Recipient Negative Lung Transplant Recipients. The Annals of thoracic surgery, 105(2), 441-447.
  26. Courtwright AM, El-Chemaly S, Dellaripa PF, Goldberg H (2017). Survival and outcomes after lung transplantation for non-scleroderma connective tissue-related interstitial lung disease. The Journal of heart and lung transplantation, 36(7), 763-769.
  27. Courtwright AM, Fried S, Villalba JA, Moniodis A, Guleria I, Wood I, Milford E, Mallidi HH, Hunninghake GM, Raby BA, Agarwal S, Camp PC, Rosas IO, Goldberg HJ, El-Chemaly (2016). Association of Donor and Recipient Telomere Length with Clinical Outcomes following Lung Transplantation. PloS one, 11(9), e0162409.
  28. Courtwright AM, Salomon S, Fuhlbrigge A, Divo M, Rosas IO, Camp PC, Mallidi HH, Burkett P, El-Chemaly S, Wolfe DJ, Goldberg H (2016). Predictors and outcomes of unplanned early rehospitalization in the first year following lung transplantation. Clinical transplantation, 30(9), 1053-8.
  29. Courtwright AM, Salomon S, Lehmann LS, Brettler T, Divo M, Camp P, Goldberg HJ, Wolfe D (2016). The association between mood, anxiety and adjustment disorders and hospitalization following lung transplantation. General hospital psychiatry, 41, 1-5.
  30. Rubin EB, Robinson EM, Cremens MC, McCoy TH, Courtwright A (2023). Declining to Provide or Continue Requested Life-Sustaining Treatment: Experience With a Hospital Resolving Conflict Policy. Journal of bioethical inquiry, 20(3), 457-466.
  31. Erler KS, Robinson EM, Bandini JI, Regel EV, Zwirner M, Cremens C, McCoy TH, Romain F, Courtwright (2023). Clinical Ethics Consultation During the First COVID-19 Pandemic Surge at an Academic Medical Center: A Mixed Methods Analysis. HEC forum, 35(4), 371-388.
  32. Rubin EB, Knipe RS, Israel RA, McCoy TH Jr, Courtwright A (2021). Existing Crisis Standards of Care Triage Protocols May Not Significantly Differentiate Between Patients With Coronavirus Disease 2019 Who Require Intensive Care. Critical care explorations, 3(4), e0412.
  33. Courtwright AM, Erler KS, Bandini JI, Zwirner M, Cremens MC, McCoy TH, Robinson EM, Rubin (2021). Ethics Consultation for Adult Solid Organ Transplantation Candidates and Recipients: A Single Centre Experience. Journal of bioethical inquiry, 18(2), 291-303.
  34. Courtwright AM, Rubin E, Erler KS, Bandini JI, Zwirner M, Cremens MC, McCoy TH, Robinson E (2022). Experience with a Revised Hospital Policy on Not Offering Cardiopulmonary Resuscitation. HEC forum, 34(1), 73-88.
  35. Milliken A, Courtwright A, Grace P, Eagan-Bengston E, Visser M, Jurchak (2020). Ethics Consultations at a Major Academic Medical Center: A Retrospective, Longitudinal Analysis. AJOB empirical bioethics, 11(4), 275-286.
  36. McCurry IJ, Han J, Courtwright (2020). How Should Physicians Manage Neuroprognosis with ECPR?. Narrative inquiry in bioethics, 10(2), 173-182.
  37. Bandini JI, Courtwright AM, Rubin E, Erler KS, Zwirner M, Cremens MC, McCoy TH, Robinson E (2020). Ethics Consultations Related to Opioid Use Disorder. Psychosomatics, 61(2), 161-170.
  38. Courtwright AM, Abrams J, Robinson E (2017). The Role of a Hospital Ethics Consultation Service in Decision-Making for Unrepresented Patients. Journal of bioethical inquiry, 14(2), 241-250.
  39. Bandini JI, Courtwright A, Zollfrank AA, Robinson EM, Cadge (2017). The role of religious beliefs in ethics committee consultations for conflict over life-sustaining treatment. Journal of medical ethics, 43(6), 353-358.
  40. Robinson EM, Cage W, Erler K, Brackett S, Bandini J, Cist A, Cremens MC, Krakauer EL, Courtwright (2017). Structure, Operation, and Experience of Clinical Ethics Consultation 2007-2013: A Report from the Massachusetts General Hospital Optimum Care Committee. The Journal of clinical ethics, 28(2), 137-152.
  41. Robinson EM, Cadge W, Zollfrank AA, Cremens MC, Courtwright A (2017). After the DNR: Surrogates Who Persist in Requesting Cardiopulmonary Resuscitation. The Hastings Center report, 47(1), 10-19.
  42. Courtwright AM, Robinson EM, Feins K, Carr-Loveland J, Donahue V, Roy N, McCannon (2016). Ethics Committee Consultation and Extracorporeal Membrane Oxygenation. Annals of the American Thoracic Society, 13(9), 1553-8.
  43. Courtwright A, Rubin (2016). Who should Decide for the Unrepresented?. Bioethics, 30(3), 173-80.
  44. Courtwright AM, Brackett S, Cadge W, Krakauer EL, Robinson E (2015). Experience with a hospital policy on not offering cardiopulmonary resuscitation when believed more harmful than beneficial. Journal of critical care, 30(1), 173-7.
  45. Courtwright A, Brackett S, Cist A, Cremens MC, Krakauer EL, Robinson E (2014). The changing composition of a hospital ethics committee: a tertiary care center's experience. HEC forum, 26(1), 59-68.
  46. Courtwright (2012). Who is "too sick to benefit"?. The Hastings Center report, 42(4), 41-7.
  47. Courtwright (2013). Stigmatization and public health ethics. Bioethics, 27(2), 74-80.
  48. Courtwright AM, Laughon MM, Doron M (2011). Length of life and treatment intensity in infants diagnosed prenatally or postnatally with congenital anomalies considered to be lethal. Journal of perinatology, 31(6), 387-91.
  49. Courtwright A (2009). Justice, stigma, and the new epidemiology of health disparities. Bioethics, 23(2), 90-6.
  50. Courtwright (2008). Health disparities and autonomy. Bioethics, 22(8), 431-9.
  51. Krymskaya VP, Courtwright AM, Fleck V, Dorgan D, Kotloff R, McCormack FX, Kreider (2020). A phase II clinical trial of the Safety Of Simvastatin (SOS) in patients with pulmonary lymphangioleiomyomatosis and with tuberous sclerosis complex. Respiratory medicine, 163, 105898.
  52. Courtwright AM, Baldi BG, Kidambi P, Cui Y, Lamattina AM, Villalba JA, Bagwe S, Goldberg HJ, Rosas IO, Henske EP, Carvalho CRR, El-Chemaly (2018). Characterization of lymphangioleiomyomatosis patients with discordance between spirometric and diffusion measurements of pulmonary function. Sarcoidosis, vasculitis, and diffuse lung diseases, 35(3), 206-212.
  53. Lamattina AM, Poli S, Kidambi P, Bagwe S, Courtwright A, Louis PH, Shrestha S, Stump B, Goldberg HJ, Thiele EA, Rosas I, Henske EP, El-Chemaly (2019). Serum endostatin levels are associated with diffusion capacity and with tuberous sclerosis- associated lymphangioleiomyomatosis. Orphanet journal of rare diseases, 14(1), 72.
  54. Courtwright A, Siamakpour-Reihani S, Arbiser JL, Banet N, Hilliard E, Fried L, Livasy C, Ketelsen D, Nepal DB, Perou CM, Patterson C, Klauber-Demore (2009). Secreted frizzle-related protein 2 stimulates angiogenesis via a calcineurin/NFAT signaling pathway. Cancer research, 69(11), 4621-8.
  55. Federico LE, Courtwright AM, Diamond JM, Crespo MM, Bermudez C (2024). Change in Panel Reactive Antibodies in Patients Bridged to Lung Transplantation With Extracorporeal Membrane Oxygenation. Seminars in thoracic and cardiovascular surgery, 36(1), 54-56.
  56. Courtwright AM, Mackintosh JA, Alder JK, Garcia CK, Froidure A, Lowery E, Hayes D Jr, Shah P, Philippot Q, Borie R, Greenland JR, Mannem H, Snyder ME, Hellemons M, Snyder LD, McDyer (2026). ISHLT Consensus Statement on Short Telomere Syndrome and Lung Transplantation: Authors' Perspective. The Journal of heart and lung transplantation, 45(2), 163-167.
  57. Courtwright AM, Diamond JM, Goldberg H (2025). Retransplant- and Bronchiolitis Obliterans Syndrome-Free Survival among COVID Lung Transplant Recipients: A National Cohort Study. Annals of the American Thoracic Society,
  58. Courtwright AM, Mackintosh JA, Alder JK, Garcia CK, Froidure A, Lowery E, Hayes D Jr, Pali S, Philippot Q, Borie R, Greenland JR, Mannem H, Snyder ME, Hellemons M, Snyder LD, McDyer (2026). ISHLT Consensus Statement on Short Telomere Syndrome and Lung Transplantation. The Journal of heart and lung transplantation, 45(2), e83-e103.
  59. Zhu D, Patel NB, Pishko AM, Weinberg EM, Takako TI, Kallish S, Johnson FB, Babushok DV, Courtwright A (2025). Evaluation of a screening protocol for telomere biology disorders in individuals with interstitial lung disease undergoing lung transplant evaluation. ERJ open research, 11(5),
  60. Courtwright A (2025). A "Messy Literature" and Administrative Gloss. The American journal of bioethics, 25(9), 69-71.
  61. Courtwright A (2025). Active smokers should not be denied access to lung transplantation. American journal of transplantation, 25(9), 1851-1857.
  62. Courtwright AM, Prenner S, Doyon JB, Claridge T, Blumberg E, Bermudez CA, Crespo M (2025). Lessons From the Utilization of Hepatitis B Virus Nucleic Acid Test Positive Donors for Hepatitis B Vaccinated Lung Transplant Candidates (INHIBITOR) Study. Transplant infectious disease, 27(4), e70013.
  63. Grobman B, Courtwright AM, Yeung M, Jacob S, Lee S, Sheikh A, Keshk M, Hackman A, Coppolino A, Dunning J, Sharma N, Goldberg H (2025). Long-Term Chronic Lung Allograft Dysfunction-Free Survival Following Lung Transplant in the Presence of Donor-Specific Antibodies. Clinical transplantation, 39(8), e70241.
  64. Federico LE, Diamond JM, Kamoun M, Crespo MM, Bermudez CA, Courtwright A (2024). Donor Specific Antibodies in Extracorporeal Membrane Oxygenation-Bridged Lung Transplant Recipients. Annals of thoracic surgery short reports, 2(4), 836-841.
  65. Clancy MJ, Tevald MA, Adler J, Butler K, Courtwright AM, Diamond JM, Crespo MM, Bermudez C (2024). Reevaluating Rehabilitation Practice for Patients Who Were Critically Ill After COVID-19 Infection: An Administrative Case Report. Physical therapy, 104(3),
  66. Ghosh AJ, Moll M, Shrestha S, Poli S, Glatt SJ, Goldberg HJ, Courtwright AM, El-Chemaly S (2024). Leveraging blood-based transcriptomics to detect acute cellular rejection in lung transplant. JHLT open, 4, 100081.
  67. Diamond JM, Cantu E, Calfee CS, Anderson MR, Clausen ES, Shashaty MGS, Courtwright AM, Kalman L, Oyster M, Crespo MM, Bermudez CA, Benvenuto L, Palmer SM, Snyder LD, Hartwig MG, Todd JL, Wille K, Hage C, McDyer JF, Merlo CA, Shah PD, Orens JB, Dhillon GS, Weinacker AB, Lama VN, Patel MG, Singer JP, Hsu J, Localio AR, Christie J (2024). The Impact of Donor Smoking on Primary Graft Dysfunction and Mortality after Lung Transplantation. American journal of respiratory and critical care medicine, 209(1), 91-100.
  68. Courtwright A (2023). The Moral Relevance of ECMO Bridge Maintenance. The American journal of bioethics, 23(6), 52-54.
  69. Clancy MJ, Adler J, Tevald MA, Zaleski D, Fluehr L, Wamsley C, Bermudez CA, Crespo MM, Balar P, Oyster ML, Courtwright AM, Diamond J (2023). Rehabilitation Characteristics and Outcomes for Lung Transplantation for COVID-19: A Case Series. Physical therapy, 103(5),
  70. Murakami N, Baggett ND, Schwarze ML, Ladin K, Courtwright AM, Goldberg HJ, Nolley EP, Jain N, Landzberg M, Wentlandt K, Lai JC, Shinall MC, Ufere NN, Jones CA, Lakin J (2022). Top Ten Tips Palliative Care Clinicians Should Know About Solid Organ Transplantation. Journal of palliative medicine, 25(7), 1136-1142.
  71. Seligman WH, Sadovnikoff N, Joubert IA, Hutton P, Flint M, Courtwright AM, Krishnamurthy KB, Joseph AM, McKechnie (2020). Variation in timing of decisions to withdraw life-sustaining treatment in adult ICU patients from three centres in different geographies: Do clinical factors explain the difference?. The Southern African journal of critical care, 36(1),
  72. Courtwright AM, Doron M (2007). Is restricting access to assisted reproductive technology an infringement of reproductive rights?. The virtual mentor, 9(9), 635-40.

Review

  1. Courtwright AM, Salomon S, Lehmann LS, Wolfe DJ, Goldberg H (2016). The Effect of Pretransplant Depression and Anxiety on Survival Following Lung Transplant: A Meta-analysis. Psychosomatics, 57(3), 238-45.
  2. Courtwright A, Jurchak (2016). The Evolution of American Hospital Ethics Committees: A Systematic Review. The Journal of clinical ethics, 27(4), 322-340.
  3. Cooper Z, Courtwright A, Karlage A, Gawande A, Block (2014). Pitfalls in communication that lead to nonbeneficial emergency surgery in elderly patients with serious illness: description of the problem and elements of a solution. Annals of surgery, 260(6), 949-57.
  4. Rubin E, Courtwright (2013). Medical futility procedures: what more do we need to know?. Chest, 144(5), 1707-1711.
  5. Courtwright A, Turner A (2010). Tuberculosis and stigmatization: pathways and interventions. Public health reports (Washington, D.C., 125 Suppl 4(Suppl 4), 34-42.
  6. Chen JA, Courtwright A, Wu K (2017). The Role of Stigma and Denormalization in Suicide-Prevention Laws in East Asia: A Sociocultural, Historical, and Ethical Perspective. Harvard review of psychiatry, 25(5), 229-240.
  7. Courtwright AM, Goldberg HJ, Henske EP, El-Chemaly (2017). The effect of mTOR inhibitors on respiratory infections in lymphangioleiomyomatosis. European respiratory review, 26(143),
  8. Courtwright A, Atkinson C, Pelaez (2023). The Highly Sensitized Recipient: Pretransplant and Posttransplant Considerations. Clinics in chest medicine, 44(1), 85-93.
  9. Courtwright AM, El-Chemaly (2019). Telomeres in Interstitial Lung Disease: The Short and the Long of It. Annals of the American Thoracic Society, 16(2), 175-181.
  10. Courtwright AM, Gabriel P (2018). Clinical Databases for Chest Physicians. Chest, 153(4), 1016-1022.
  11. Courtwright A, Cantu (2017). Evaluation and Management of the Potential Lung Donor. Clinics in chest medicine, 38(4), 751-759.
  12. Mezochow AK, Clausen E, Whitaker K, Claridge T, Blumberg E, Courtwright A (2025). Letermovir should be first-line cytomegalovirus prophylaxis in lung transplant recipients. American journal of transplantation, 25(5), 908-915.
  13. Courtwright AM, Whyte AM, Devarajan J, Fritz AV, Martin AK, Wilkey B, Stollings L, Cassara CM, Tawil JN, Miltiades AN, Bottiger BA, Pollak AL, Boisen ML, Harika RS, Street C, Terracciano W, Green J, Subramani S, Gelzinis T (2024). The Year in Cardiothoracic Transplant Anesthesia: Selected Highlights From 2022 Part I: Lung Transplantation. Journal of cardiothoracic and vascular anesthesia, 38(11), 2516-2545.
  14. Sise ME, Courtwright AM, Channick R (2013). Pulmonary hypertension in patients with chronic and end-stage kidney disease. Kidney international, 84(4), 682-92.
  15. Courtwright AM, He (2002). Dam1 is the right one: phosphoregulation of kinetochore biorientation. Developmental cell, 3(5), 610-1.

Commentary

  1. Courtwright A (2023). Normothermic Regional Perfusion, Causes, and the Dead Donor Rule. The American journal of bioethics, 23(2), 46-47.
  2. Courtwright A (2020). When Exclusion Criteria Are Appropriate. The American journal of bioethics, 20(7), 158-160.
  3. Lamas DJ, Lakin JR, Trindade AJ, Courtwright A, Goldberg (2018). Looking beyond Mortality in Transplantation Outcomes. The New England journal of medicine, 379(20), 1889-1891.
  4. Courtwright A, El-Chemaly (2017). Broadening the investigation-short telomeres and lung transplantation outcomes in pulmonary fibrosis. The Journal of heart and lung transplantation, 36(8), 833-834.
  5. Courtwright (2011). Shared health governance and the problem of stability. The American journal of bioethics, 11(7), 47-9.
  6. Courtwright (2008). The social determinants of health: moving beyond justice. The American journal of bioethics, 8(10), 16-7.

Case Report

  1. Modi P, Qiu L, Fallah T, Courtwright A, Halpern C (2023). Magnetic Resonance Guided Focused Ultrasound Thalamotomy for Treatment of Severe Essential Tremor in a Lung Transplant Recipient-A Case Report. Transplantation proceedings, 55(8), 1988-1990.
  2. Nachiappan A, Fallah T, Willert R, Chojnowski D, Deshpande C, Courtwright (2022). Severe Acute Cellular Rejection With High-Grade Lymphocytic Bronchiolitis Following Transition from Tacrolimus to Belatacept in a Lung Transplantation Recipient: A Case Report. Transplantation proceedings, 54(1), 165-168.
  3. Courtwright AM, Longworth S, Chojnowski D, Lee I, Hunt (2021). Treatment of a Pulmonary Aspergilloma in a Lung Transplant Recipient Using Catheter-directed Intracavitary Instillation of Liposomal Amphotericin B. Transplantation direct, 8(1), e1270.
  4. Jacob S, Courtwright A, El-Chemaly S, Racila E, Divo M, Burkett P, Fuhlbrigge A, Goldberg HJ, Rosas IO, Camp (2016). Donor-acquired fat embolism syndrome after lung transplantation. European journal of cardio-thoracic surgery, 49(5), 1344-7.

Other

  1. Holm AM, Fedson S, Courtwright A, Olland A, Bryce K, Kanwar M, Sweet S, Egan T, Lavee (2022). International society for heart and lung transplantation statement on transplant ethics. The Journal of heart and lung transplantation, 41(10), 1307-1308.
  2. Holm AM, Courtwright A, Olland A, Zuckermann A, Van Raemdonck (2022). ISHLT position paper on thoracic organ transplantation in controlled donation after circulatory determination of death (cDCD). The Journal of heart and lung transplantation, 41(6), 671-677.
  3. Holm AM, Mehra MR, Courtwright A, Teuteberg J, Sweet S, Potena L, Singer LG, Farrero M, Shullo MA, Benza R, Ensminger S, Aslam (2020). Ethical considerations regarding heart and lung transplantation and mechanical circulatory support during the COVID-19 pandemic: an ISHLT COVID-19 Task Force statement. The Journal of heart and lung transplantation, 39(7), 619-626.